Differential susceptibility to hydrogen sulfide-induced apoptosis between PHLDA1-overexpressing oral cancer cell lines and oral keratinocytes: Role of PHLDA1 as an apoptosis suppressor

Experimental Cell Research

Volumn 320, Issue 2, 2014, Pages 247-257

  Murata, Takatoshi ^a,b   Sato, Tsutomu ^b   Kamoda, Takeshi ^b   Moriyama, Hiromitsu ^c   Kumazawa, Yasuo ^b   Hanada, Nobuhiro ^a  

^a TSURUMI UNIVERSITY   (Japan)

^b NIPPON DENTAL UNIVERSITY   (Japan)

^c TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

Author keywords

Apoptosis susceptibility; Hydrogen sulfide; Oral cancer; PHLDA1

Indexed keywords

APOPTOSIS INDUCING FACTOR; CASPASE 3; DACTINOMYCIN; HYDROGEN SULFIDE; PLECKSTRIN; PLECKSTRIN HOMOLOGY LIKE DOMAIN FAMILY A MEMBER 1; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BACTERIAL COLONIZATION; CANCER CELL CULTURE; DIFFERENTIAL DISPLAY; FLOW CYTOMETRY; GENE EXPRESSION; GENE SILENCING; GINGIVA; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; KERATINOCYTE; MOUTH CANCER; MOUTH CAVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SUPPRESSOR CELL; TONGUE CANCER;

7-AAD; 7-AMINO-ACTINOMYCIN D; ACP; ANALYSIS OF VARIANCE; ANNEALING CONTROL PRIMERS; ANNEXIN V-PE; ANOVA; APOPTOSIS SUSCEPTIBILITY; H(2)S; HYDROGEN SULFIDE; ORAL CANCER; PHLDA1; PHYCOERYTHRIN-CONJUGATED ANNEXIN V; PLECKSTRIN HOMOLOGY-LIKE DOMAIN, FAMILY A, MEMBER 1; SEM; SIRNA; SMALL INTERFERING RNA; STANDARD ERROR OF THE MEAN;

APOPTOSIS; BASE SEQUENCE; CELLS, CULTURED; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYDROGEN SULFIDE; KERATINOCYTES; MOLECULAR SEQUENCE DATA; MOUTH MUCOSA; MOUTH NEOPLASMS; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS;

EID: 84890858026     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2013.10.023     Document Type: Article

References (27)

1. International Agency for Research on Cancer. GLOBOCAN 2008. (3 June 2013, date last accessed). http://www.globocan.iarc.fr.
2. Persson S., Edlund M.B., Claesson R., Carlsson J. The formation of hydrogen sulfide and methyl mercaptan by oral bacteria. Oral Microbiol. Immunol. 1990, 5:195-201.
3. Murata T., Yamaga T., Iida T., Miyazaki H., Yaegaki K. Classification and examination of halitosis. Int. Dent. J. 2002, 52(Suppl. 3):181-186.
4. Hosoki R., Matsuki N., Kimura H. The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochem. Biophys. Res. Commun. 1997, 237:527-531.
5. Wang R. The gasotransmitter role of hydrogen sulfide. Antioxid. Redox Signal. 2003, 5:493-501.
6. Li L., Rose P., Moore P.K. Hydrogen sulfide and cell signalling. Annu. Rev. Pharmacol. Toxicol. 2011, 51:169-187.
7. Wang R. Two's company, three's a crowd: can H2S be the third endogenous gaseous transmitter?. FASEB J. 2002, 13:1792-1798.
8. Murata T., Yaegaki K., Qian W., Herai M., Calenic B., Imai T., Sato T., Tanaka T., Kamoda T., Ii H. Hydrogen sulfide induces apoptosis in epithelial cells derived from human gingival. J. Breath Res. 2008, 2:017007.
9. Calenic B., Yaegaki K., Murata T., Imai T., Aoyama I., Sato T., Ii H. Oral malodorous compound triggers mitochondrial-dependent apoptosis and causes genomic DNA damage in human gingival epithelial cells. J. Periodontal Res. 2010, 45:31-37.
10. Lee Z.W., Zhou J., Chen C.S., Zhao Y., Tan C.H., Li L., Moore P.K., Deng L.W. The slow-releasing hydrogen sulfide donor, GYY4137, exhibits novel anti-cancer effects in vitro and in vivo. PLoS One 2011, 6:e21077.
11. Haslam R.J., Koide H.B., Hemmings B.A Pleckstrin domain homology. Nature. -310 1993, 363:309.
12. Ingley E., Hemmings B.A Pleckstrin homology (PH) domains in signal transduction. J. Cell Biochem. 1994, 56:436-443.
13. Saraste M, Hyvönen M. Pleckstrin homology domains: a fact file. Curr. Opin. Struct. Biol. 1995, 5:403-408.
14. Park C.G., Lee S.Y., Kandala G., Lee S.Y., Choi Y. A novel gene product that couples TCR signaling to Fas (CD95) expression in activation-induced cell death. Immunity 1996, 4:583-591.
15. Rho J., Gong S., Kim N., Choi Y. TDAG51 is not essential for Fas/CD95 regulation and apoptosis in vivo. Mol. Cell. Biol. 2001, 21:8365-8370.
16. Hossain G.S., van Thienen J.V., Werstuck G.H., Zhou J., Sood S.K., Dickhout J.G., de Koning A.B., Tang D., Wu D., Falk E., Poddar R., Jacobsen D.W., Zhang K., Kaufman R.J., Austin R.C. TDAG51 is induced by homocysteine, promotes detachment-mediated programmed cell death, and contributes to the development of atherosclerosis in hyperhomocysteinemia. J. Biol. Chem. 2003, 278:30317-30327.
17. Joo J.H., Liao G., Collins J.B., Grissom S.F., Jetten A.M. Farnesol-induced apoptosis in human lung carcinoma cells is coupled to the endoplasmic reticulum stress response. Cancer Res. 2007, 67. (7929-7236).
18. Gomes I., Xiong W., Miki T., Rosner M.R. A proline- and glutamine-rich protein promotes apoptosis in neuronal cells. J. Neurochem. 1999, 73:612-622.
19. Neef R., Kuske M.A., Pröls E., Johnson J.P. Identification of the human PHLDA1/TDAG51 gene: down-regulation in metastatic melanoma contributes to apoptosis resistance and growth deregulation. Cancer Res. 2002, 62:5920-5929.
20. Hayashida N., Inouye S., Fujimoto M., Tanaka Y., Izu H., Takaki E., Ichikawa H., Rho J., Nakai A. A novel HSF1-mediated death pathway that is suppressed by heat shock proteins. EMBO J. 2006, 25:4773-4783.
21. Toyoshima Y., Karas M., Yakar S., Dupont J., Helman L., LeRoith D. TDAG51 mediates the effects of insulin-like growth factor I (IGF-I) on cell survival. J. Biol. Chem. 2004, 279:25898-25904.
22. Persson S. Hydrogen sulfide and methyl mercaptan in periodontal pockets. Oral Microbiol. Immunol. 1992, 7:378-379.
23. Murata T., Fujiyama Y., Yamaga T., Miyazaki H. Breath malodor in an asthmatic patient caused by side-effects of medication: a case report and review of the literature. Oral Dis. 2003, 9:273-276.
24. Sakthianandeswaren A., Christie M., D'Andreti C., Tsui C., Jorissen R.N., Li S., Fleming N.I., Gibbs P., Lipton L., Malaterre J., Ramsay R.G., Phesse T.J., Ernst M., Jeffery R.E., Poulsom R., Leedham S.J., Segditsas S., Tomlinson I.P., Bernhard O.K., Simpson R.J., Walker F., Faux M.C., Church N., Catimel B., Flanagan D.J., Vincan E., Sieber O.M. PHLDA1 expression marks the putative epithelial stem cells and contributes to intestinal tumorigenesis. Cancer Res. 2011, 71:3709-3719.
25. Nagai M.A., Fregnani J.H., Netto M.M., Brentani M.M., Soares F.A. Down-regulation of PHLDA1 gene expression is associated with breast cancer progression. Breast Cancer Res. Treat. 2007, 106:49-56.
26. Chiu S.T., Hsieh F.J., Chen S.W., Chen C.L., Shu H.F., Li H. Clinicopathologic correlation of up-regulated genes identified using cDNA microarray and real-time reverse transcription-PCR in human colorectal cancer. Cancer Epidemiol. Biomarkers Prev. 2005, 14:437-443.
27. Sellheyer K., Krahl D. PHLDA1 (TDAG51) is a follicular stem cell marker and differentiates between morphoeic basal cell carcinoma and desmoplastic trichoepithelioma. Br. J. Dermatol. 2011, 164:141-147.